Posts

Our Edinburgh research centre is moving!

We are delighted to share that we are moving our Edinburgh base and headquarters to a newly refurbished research facility within Scottish Gas Murrayfield stadium.

Lecanemab is approved by MHRA in Great Britain, and restricted in NHS

Following today’s announcements from the MHRA and NICE about a new drug, lecanemab – which approve its use in Great Britain, but block its adoption in NHS England – our CEO and Founder, Prof Craig Ritchie has responded.

New Alzheimer’s Vaccine Trial in Scotland

Scottish Brain Sciences is delighted to be the first clinical site open in the UK & Europe, to deliver a clinical trial of a new active immunotherapy (a vaccine) aimed at preventing or slowing the progression of Alzheimer’s Disease.